Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 5 Stomach Neoplasms 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 28 Trastuzumab 16 Paclitaxel 14 Docetaxel 12 Cyclophosphamide 11 Capecitabine 11 Nivolumab 9 fludarabine 7 Carboplatin 7 Oxaliplatin 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 Specimen Handling 5 Leucovorin 5 Irinotecan 5 Injections 5 Gemcitabine 5 Fluorouracil 5 Bevacizumab 5 atezolizumab 4 aldesleukin 4 Taxes 4 Ipilimumab 4 Fluorodeoxyglucose F18 4 Drug Therapy 4 Cetuximab 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 zanidatamab 3 veliparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Imiquimod × Breast × Clear all

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡